Pembrolizumab-induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in Non-small Cell Lung Cancer

Autor: Yoshitaka Iwamoto, Daisuke Minami, Taichi Ozeki, Sachi Okawa, Takuo Shibayama, Hiroe Kayatani, Ken Sato, Kenji Takada, Keiichi Fujiwara
Rok vydání: 2019
Předmět:
Male
medicine.medical_specialty
Lung Neoplasms
Bilirubin
Prednisolone
Jaundice
Case Report
Pembrolizumab
030204 cardiovascular system & hematology
Antibodies
Monoclonal
Humanized

Gastroenterology
Lymphohistiocytosis
Hemophagocytic

immune checkpoint inhibitors
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Carcinoma
Non-Small-Cell Lung

Internal medicine
Internal Medicine
medicine
Humans
Lung cancer
Glucocorticoids
non-small cell lung cancer
autoimmune hemolytic anemia
Aged
Hemophagocytic lymphohistiocytosis
business.industry
General Medicine
medicine.disease
Coombs Test
Treatment Outcome
hemophagocytic lymphohistiocytosis
chemistry
Carcinoma
Squamous Cell

030211 gastroenterology & hepatology
pembrolizumab
Anemia
Hemolytic
Autoimmune

Non small cell
medicine.symptom
Autoimmune hemolytic anemia
business
medicine.drug
Zdroj: Internal Medicine
ISSN: 1349-7235
0918-2918
DOI: 10.2169/internalmedicine.1001-18
Popis: We herein report a 78-year old man with squamous cell carcinoma of the lungs treated with pembrolizumab. At 10 days after the administration of pembrolizumab, he showed progressive anemia and increased levels of bilirubin. Because the findings of a direct coombs test and cold hemagglutinin were positive, we diagnosed the patient with autoimmune hemolytic anemia and treated him with prednisolone. Subsequently, he was admitted to our hospital owing to fatigue, a high fever, and jaundice. His clinical findings met the diagnostic criteria of hemophagocytic lymphohistiocytosis, and he was rescued with a high dose of glucocorticoids. Marked tumor regression was obtained and has been maintained since then.
Databáze: OpenAIRE